#5on5 CF Month Series
May is Cystic Fibrosis Awareness Month. More than 70,000 people worldwide live with CF, and for one in ten of them, there are currently no effective, disease-modifying treatments available. At Translate Bio, we are making progress in the development of an mRNA therapy for this disease, which has the potential to treat all CF patients regardless of their genetic mutation.
#5on5 CF Month Series
This CF awareness month, we’re launching a special video series called #5on5. The series will cover 5 questions over the 5 Fridays of May, bringing in various perspectives from the CF community including a patient advocate with CF, CF parent, CF advocacy leader, CF physician, clinical research and scientist.
Lianne Boeglin, CF Scientist, Translate Bio
Arek Puzia, CF Parent and Advocate
Siri Vaeth, Executive Director, CFRI and CF Parent
Meagan Vaughn, CF Clinical Scientist, Translate Bio
Colleen Veitengruber, Advocate with Cystic Fibrosis
Dr. Jonathan Zuckerman, MD, Director, Maine Medical Center’s Adult Cystic Fibrosis Clinic
#5on5 Series: Week 1 – May 1, 2020
Our first #5on5 explores what a treatment option that works for 100% of the #CF community would mean – what if we could reach the final 10% of people with CF awaiting treatments?
#5on5 Series – Week 2 – May 8, 2020
Our next #5on5 dives into how the treatment paradigm for people with CF has changed over the last year and asks– what’s next?
#5on5 Series – Week 3 – May 15, 2020
Our next #5on5 explores therapies in development that give us hope for the entire cystic fibrosis community, including the remaining 10% of people with CF who do not benefit from currently approved therapies.
#5on5 Series – Week 4 – CF Community
On our next #5on5, we ask community participants to describe the CF community. A few of their answers: Resilient, hopeful, positive, connected, informed and supportive. Hear what else they had to say below!
#5on5 Series – Week 5 – Navigating COVID-19
On our next and final #5on5, we ask our community participants what they hope people will take away from navigating the COVID-19 pandemic. What can we learn from the CF community during these unprecedented times?